Company: LIMN
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001104659-25-010605
Chunk: 247

Company: Liminatus Pharma, Inc.
Filing Date: 2025-02-07
Form: 424B3
Chunk 247
---
 Transactions contemplated by the Business Combination Agreement were advisable and in the best interests of Iris and its stockholders. See “ — Interests of Certain Persons in the Business Combination .”

### Liminatus Consideration of the Business Combination
On November 30, 2022, Liminatus: (i) approved the Business Combination Agreement and the transactions contemplated thereby, (ii) determined that the Business Combination is fair to, advisable, and in the best interest of Liminatus and its members, and (iii) recommended that the members of Liminatus approve the Business Combination Agreement and the transactions contemplated thereby. In evaluating the Business Combination and making these determinations and this recommendation, Liminatus consulted with Liminatus’s senior management, Liminatus’s legal counsel and its other advisors and considered a number of factors.

The Liminatus management also considered the general criteria and guidelines that Liminatus believed would be important in evaluating prospective business combination partners. In considering the Business Combination, the Liminatus management determined that the Business Combination provided the benefits below, although not weighted or in any order of significance. In light of the factors described below, the Liminatus management determined the Business Combination was an attractive business opportunity.

The Liminatus management’s evaluation relating to the merits of the Business Combination were based on considerations, factors, criteria and guidelines that Liminatus’s management team deemed relevant. In light of the complexity of those factors, Liminatus’s management as a whole did not consider it practicable to, nor did it attempt to, quantify or otherwise assign relative weights to the specific factors it took into account in reaching their respective decisions. Individual members of Liminatus’s management may have given different weight to different factors.

In particular, the Liminatus management considered the following factors:

•

Liminatus’s operating results and financial performance;

•

the current business conditions;

•

the stage of development of Liminatus’s products and services;

•

the likelihood of achieving a liquidity event, such as an initial public offering, given prevailing market conditions and the nature and history of Liminatus’s business;

•

industry information such as market size and growth;

•

the macroeconomic conditions;

•

the effect of an infusion of working capital on Liminatus’s business and growth strategies; and

<div align='center'>118</div>

TABLE OF CONTENTS

•

the desire of potential customers to deal with a publicly traded Nasdaq-listed Delaware corporation.

### Interests of Certain Persons in the Business Combination
In considering the recommendation of